Lilly’s Mounjaro and Zepbound No Longer on FDA Drug Shortage List

All doses of Eli Lilly’s type 2 diabetes medication Mounjaro and weight-loss drug Zepbound are now available, according to an update on Friday to the FDA’s drug shortage database.